GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
6W1J | Q8K1F4 | Cryo-EM structure of 5HT3A receptor in presence of Alosetron | 5-hydroxytryptamine receptor 3A |
6W1M | Q8K1F4 | Cryo-EM structure of 5HT3A receptor in presence of Ondansetron | 5-hydroxytryptamine receptor 3A |
6W1Y | Q8K1F4 | Cryo-EM structure of 5HT3A receptor in presence of Palonosetron | 5-hydroxytryptamine receptor 3A |
6NP0 | E9QLC0 | Cryo-EM structure of 5HT3A receptor in presence of granisetron | 5-hydroxytryptamine receptor 3A |
7W02 | Q99758 | Cryo-EM structure of ATP-bound ABCA3 | |
7JHG | Q13131 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody | |
7JHG | O43741 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody | |
7JHG | P54619 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody | |
7JHG | 7JHG | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody | |
7JHG | C3SHQ8 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody | |
7JHH | Q13131 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody | |
7JHH | O43741 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody | |
7JHH | P54619 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody | |
7JHH | 7JHH | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody | |
7JHH | C3SHQ8 | Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody | |
7N72 | Q9NQ11 | Cryo-EM structure of ATP13A2 in the AlF-bound E2-Pi-like state | |
7N70 | Q9NQ11 | Cryo-EM structure of ATP13A2 in the BeF-bound E2P-like state | |
7N78 | Q9NQ11 | Cryo-EM structure of ATP13A2 in the E2-Pi state | |
8OX4 | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E1-ATP conformation | |
8OX4 | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E1-ATP conformation | |
8OX6 | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E1P conformation | |
8OX6 | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E1P conformation | |
8OX5 | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E1P-ADP conformation | |
8OX5 | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E1P-ADP conformation | |
8OXB | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E2-Pi conformation with occluded PC | |
8OXB | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E2-Pi conformation with occluded PC | |
8OXC | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E2-Pi conformation with occluded PI | |
8OXC | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E2-Pi conformation with occluded PI | |
8OXA | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E2-Pi conformation with occluded PS | |
8OXA | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E2-Pi conformation with occluded PS | |
8OX9 | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E2P active conformation with bound PC | |
8OX9 | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E2P active conformation with bound PC | |
8OX7 | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E2P autoinhibited "closed" conformation | |
8OX7 | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E2P autoinhibited "closed" conformation | |
8OX8 | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E2P autoinhibited "open" conformation | |
8OX8 | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E2P autoinhibited "open" conformation | |
7PY4 | O43520 | Cryo-EM structure of ATP8B1-CDC50A in E2P autoinhibited state | |
7PY4 | Q9NV96 | Cryo-EM structure of ATP8B1-CDC50A in E2P autoinhibited state | |
7V4T | A0MNM2 | Cryo-EM structure of Alphavirus M1 | |
7UKL | P0DTC2 | Cryo-EM structure of Antibody 12-16 in complex with prefusion SARS-CoV-2 Spike glycoprotein | |
7UKL | 7UKL | Cryo-EM structure of Antibody 12-16 in complex with prefusion SARS-CoV-2 Spike glycoprotein | |
7UKM | P0DTC2 | Cryo-EM structure of Antibody 12-19 in complex with prefusion SARS-CoV-2 Spike glycoprotein | |
7UKM | 7UKM | Cryo-EM structure of Antibody 12-19 in complex with prefusion SARS-CoV-2 Spike glycoprotein | |
7XGD | P08069 | Cryo-EM structure of Apo-IGF1R map 1 | |
7UGQ | D7S1H2 | Cryo-EM structure of BG24 Fabs with an inferred germline CDRL1 and 10-1074 Fabs in complex with HIV-1 Env 6405-SOSIP.664 | |
7UGQ | 7UGQ | Cryo-EM structure of BG24 Fabs with an inferred germline CDRL1 and 10-1074 Fabs in complex with HIV-1 Env 6405-SOSIP.664 | |
7UGP | Q2N0S5 | Cryo-EM structure of BG24 Fabs with an inferred germline light chain and 10-1074 Fabs in complex with HIV-1 Env immunogen BG505-SOSIPv4.1-GT1 containing the N276 gp120 glycan- Class 1 | |
7UGP | 7UGP | Cryo-EM structure of BG24 Fabs with an inferred germline light chain and 10-1074 Fabs in complex with HIV-1 Env immunogen BG505-SOSIPv4.1-GT1 containing the N276 gp120 glycan- Class 1 | |
7UGN | Q2N0S5 | Cryo-EM structure of BG24 inferred germline Fabs with germline CDR3s and 10-1074 Fabs in complex with HIV-1 Env immunogen BG505-SOSIPv4.1-GT1 - Class 1 | |
7UGN | 7UGN | Cryo-EM structure of BG24 inferred germline Fabs with germline CDR3s and 10-1074 Fabs in complex with HIV-1 Env immunogen BG505-SOSIPv4.1-GT1 - Class 1 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024